Method for treating and/or preventing retinal diseases with sustained release corticosteroids
First Claim
Patent Images
1. A method for administering a corticosteroid to a posterior segment of an eye, the method comprising the step of:
- implanting a sustained release device to deliver the corticosteroid to the vitreous of the eye and wherein aqueous corticosteroid concentration is less than vitreous corticosteroid concentration during release.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a method for administering a corticosteroid to a posterior segment of an eye. In the method, a sustained release device is implanted to deliver the corticosteroid to the eye. The aqueous corticosteroid concentration remains less than vitreous corticosteroid concentration during release of the corticosteroid from the device.
-
Citations
16 Claims
-
1. A method for administering a corticosteroid to a posterior segment of an eye, the method comprising the step of:
implanting a sustained release device to deliver the corticosteroid to the vitreous of the eye and wherein aqueous corticosteroid concentration is less than vitreous corticosteroid concentration during release. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
16. An implantable, sustained release device for administering a corticosteroid to a posterior segment of an eye, the device comprising:
a corticosteroid, wherein the device is configured to provide sustained release of the corticosteroid to the vitreous of the eye such that aqueous corticosteroid concentration remains less than vitreous corticosteroid concentration during the release.
Specification